Astellas Pharma (Astellas Pharma) Sale Of Investment : $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Sale Of Investment?

Astellas Pharma's sale of investment for the three months ended in Dec. 2023 was $0 Mil. It means Astellas Pharma gained $0 Mil from selling investments. Astellas Pharma's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Compared with last quarter ($0 Mil in Sep. 2023 ), Astellas Pharma gained the same money from selling investments in Dec. 2023 ($0 Mil).

Astellas Pharma Sale Of Investment Historical Data

The historical data trend for Astellas Pharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Sale Of Investment Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sale Of Investment

Get a 7-Day Free Trial

47.02

94.45

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Astellas Pharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Astellas Pharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.